CY1123049T1 - Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους - Google Patents

Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους

Info

Publication number
CY1123049T1
CY1123049T1 CY20201100331T CY201100331T CY1123049T1 CY 1123049 T1 CY1123049 T1 CY 1123049T1 CY 20201100331 T CY20201100331 T CY 20201100331T CY 201100331 T CY201100331 T CY 201100331T CY 1123049 T1 CY1123049 T1 CY 1123049T1
Authority
CY
Cyprus
Prior art keywords
vaccine
mycobacter
recombinant
human use
relates
Prior art date
Application number
CY20201100331T
Other languages
English (en)
Inventor
Leander Grode
Original Assignee
Vakzine Projekt Management Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vakzine Projekt Management Gmbh filed Critical Vakzine Projekt Management Gmbh
Publication of CY1123049T1 publication Critical patent/CY1123049T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η εφεύρεση σχετίζεται με ένα καινοφανές ανασυνδυασμένο εμβόλιο που παρέχει προστατευτική ανοσία σε ανθρώπινα υποκείμενα.
CY20201100331T 2010-09-20 2020-04-07 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους CY1123049T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38437510P 2010-09-20 2010-09-20
PCT/EP2011/066131 WO2012038348A1 (en) 2010-09-20 2011-09-16 Recombinant mycobacterium as vaccine for use in humans
EP11755362.8A EP2618837B1 (en) 2010-09-20 2011-09-16 Recombinant mycobacterium as vaccine for use in humans

Publications (1)

Publication Number Publication Date
CY1123049T1 true CY1123049T1 (el) 2021-10-29

Family

ID=44645725

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181100918T CY1120748T1 (el) 2010-09-20 2018-09-04 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
CY20201100331T CY1123049T1 (el) 2010-09-20 2020-04-07 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY181100918T CY1120748T1 (el) 2010-09-20 2018-09-04 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους

Country Status (26)

Country Link
US (1) US9084749B2 (el)
EP (2) EP2618837B1 (el)
JP (1) JP5919276B2 (el)
KR (1) KR101907222B1 (el)
CN (1) CN103118703A (el)
AU (1) AU2011304385B2 (el)
BR (1) BR112013006245A2 (el)
CA (1) CA2811158C (el)
CU (1) CU24182B1 (el)
CY (2) CY1120748T1 (el)
DK (2) DK3360569T3 (el)
EA (1) EA026661B1 (el)
ES (2) ES2685928T3 (el)
HK (1) HK1258603A1 (el)
HR (2) HRP20181387T1 (el)
HU (2) HUE048774T2 (el)
LT (2) LT3360569T (el)
MX (1) MX346708B (el)
PL (2) PL2618837T3 (el)
PT (2) PT3360569T (el)
RS (2) RS60146B1 (el)
SG (1) SG188595A1 (el)
SI (2) SI3360569T1 (el)
UA (1) UA112297C2 (el)
WO (1) WO2012038348A1 (el)
ZA (1) ZA201301187B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2654783T1 (sl) * 2010-12-21 2017-02-28 Max-Planck-Gesellschaft zur Fourderung der Wissenschaften e.V. Rekombinantni mycobacterium kot cepivo
EP3090757A1 (en) * 2015-05-04 2016-11-09 Vakzine Projekt Management GmbH Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
KR102338845B1 (ko) 2020-05-22 2021-12-13 서울대학교산학협력단 플랩 구동 장치 및 회전익기의 블레이드

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733151A (en) 1996-08-23 1998-03-31 Edsall; David Electrical clamping connection device
AUPO761697A0 (en) 1997-06-30 1997-07-24 Cardiac Crc Nominees Pty Limited Process for the purification of polyethers
EP0902086A1 (en) * 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
CN1513551A (zh) * 2002-09-09 2004-07-21 丛繁滋 复合生物制品组合物及其制备方法
CN1798762B (zh) 2003-04-23 2010-04-28 马普科技促进协会 效能提高的结核病疫苗
EP1649869A1 (en) * 2004-10-21 2006-04-26 Vakzine Projekt Management GmbH Combination of a recombinant mycobacterium and a biologically active agent as a vaccine

Also Published As

Publication number Publication date
US20130280287A1 (en) 2013-10-24
EP2618837A1 (en) 2013-07-31
PT2618837T (pt) 2018-10-18
HUE039038T2 (hu) 2018-12-28
EA026661B1 (ru) 2017-05-31
HRP20181387T1 (hr) 2018-11-02
DK3360569T3 (da) 2020-04-06
JP5919276B2 (ja) 2016-05-18
LT2618837T (lt) 2018-09-25
JP2013538225A (ja) 2013-10-10
ES2685928T3 (es) 2018-10-15
WO2012038348A1 (en) 2012-03-29
PT3360569T (pt) 2020-04-17
ZA201301187B (en) 2013-09-25
KR20140017484A (ko) 2014-02-11
DK2618837T3 (en) 2018-10-01
CA2811158A1 (en) 2012-03-29
SI3360569T1 (sl) 2020-07-31
CU24182B1 (es) 2016-07-29
MX2013002989A (es) 2013-10-17
CU20130041A7 (es) 2013-06-28
CN103118703A (zh) 2013-05-22
HRP20200610T1 (hr) 2020-10-02
CA2811158C (en) 2019-06-25
HUE048774T2 (hu) 2020-08-28
AU2011304385B2 (en) 2015-02-26
EP3360569B1 (en) 2020-03-18
US9084749B2 (en) 2015-07-21
MX346708B (es) 2017-03-29
EP2618837B1 (en) 2018-08-08
LT3360569T (lt) 2020-05-11
UA112297C2 (uk) 2016-08-25
CY1120748T1 (el) 2019-12-11
AU2011304385A1 (en) 2013-03-21
SI2618837T1 (sl) 2018-11-30
BR112013006245A2 (pt) 2016-06-07
ES2784451T3 (es) 2020-09-25
EP3360569A1 (en) 2018-08-15
SG188595A1 (en) 2013-04-30
HK1258603A1 (zh) 2019-11-15
EA201300380A1 (ru) 2013-07-30
RS57574B1 (sr) 2018-11-30
PL2618837T3 (pl) 2018-11-30
KR101907222B1 (ko) 2018-10-11
RS60146B1 (sr) 2020-05-29
PL3360569T3 (pl) 2020-07-27

Similar Documents

Publication Publication Date Title
CY1120730T1 (el) Απο του στοματος χορηγουμενη δοσολογια ενωσεων glp-1
DK2940135T5 (da) Heterodimeriseret polypeptid
UY34411A (es) Inmunoenlazantes dirigidos contra esclerostina
CO7061035A2 (es) Péptido de tránsito al cloroplasto
DK2920511T3 (da) Kunstig belysningsindretning til at generere naturligt lys
UY34409A (es) Inmunoenlazadores dirigidos contra el tnf
BR112014033077A2 (pt) combinação de vacina.
PH12014502840B1 (en) Vaccine compositions
CO7020893A2 (es) Conjunto de desgaste
BR112015012907A2 (pt) composição de cuidado pessoal
CY1118539T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο
UY34582A (es) Anticuerpos anti-cxcr3
CY1123049T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
UY4210Q (es) Silla
CY1121067T1 (el) Εμβολιο πεπτιδιου pcsk9
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
MA37989A1 (fr) Amines cycliques
EA201390955A1 (ru) Слитый белок robo1-fc для применения в лечении гепатокарциномы
UY34286A (es) Diagnóstico de vacuna mejorado
BR112014027230A2 (pt) lanterna com punho de fixação integrado
UY34501A (es) ?procedimiento de purificación de factor viii?.
UY4247Q (es) Silla
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
ES1076359Y (es) Implante dental
CY1117742T1 (el) Ταπενταδολη για χρησιμοποιηση στη θεραπεια συνδρομου ευερεθιστου εντερου